Plasmodium, the malarial parasite, degrades hemoglobin in host erythrocytes to use the catabolic products as a source of amino acids during development and proliferation. This is accompanied by a release of free heme. The free heme is oxidatively active and toxic to both the host cell and the malarial parasite, and it causes parasite death. Due to the absence of heme oxygenase, the parasite is unable to cleave heme into an open-chain tetrapyrrole, which is necessary for cellular excretion (8) . To protect itself, the parasite detoxifies free heme via neutralization with histidine-rich protein 2 (14, 23) , degradation with reduced glutathione (2, 13), or crystallization into hemozoin (HZ) which is a water-insoluble malarial pigment produced in the food vacuole (12, 23) . Chloroquine and other antimalarial drugs have been demonstrated to inhibit the formation of synthetic heme crystal, β-hematin (BH) which is structurally identical to hemozoin (21, 24) , and are believed to inhibit hemozoin formation in the food vacuole of malarial parasite. Current reports indicated that blocking the BH formation is an ideal target for antimalarial screening (1, 19, 22) . Several factors such as thermos (9), histidine-rich protein (14, 23) , lipid (6, 25) , and pre-formed BH (22) have been reportedly responsible for promoting BH formation. However, the thermal BH crystallization is not natural and nonphysiological process. Some strains of Plasmodium lack histidine-rich proteins, but still form HZ (22) suggesting that histidine-rich proteins are sufficient but not completely necessary for HZ formation. Therefore, two most important and natural initiators of BH formation are probably lipids and pre-formed BH. Several studies have used pre-formed BH (4, 6, 7) and lipids extracted from parasites (11), infected plasma (25) , or commercial lecithin (27) as an initiator of BH formation assay.
However, the pre-formed BH based assay has a high background absorbance in the Hemin chloride (16.3 mg, Sigma) was dissolved in 1 ml of dimethyl sulfoxide.
A C C E P T E D
The solution was passed through a 0.2-µm pore membrane filter to remove insoluble particles. The solution can be kept at 4°C up to 1 month as a stock solution (27) , and diluted to 111.1 µM of heme with 1 M acetate buffer, pH4.8, just before using. In order to determine heme concentration in stock solution, the absorbance at 400 nm was measured after the solution was diluted with 2.5% of sodium dodecyl sulfate in 0.1 M NaOH. The heme concentration was calculated with an extinction coefficient of 10 5 at 400 nm as described previously (13) . µM of heme in all assays to evaluate the effect of drugs on BH formation.
To establish effective conditions for BH formation, we studied the efficiency of BH formation induced by various concentrations of Tween 20 in vitro at 37 °C.
One hundred microliters of Tween 20 (various concentrations in serial 1:2 dilutions by distilled water) was added in each well of a 96-well plate. Next, 100 µl of heme (50 µM, buffered by 1 M acetate buffer, pH4.8) was added to each well and incubated at 37 °C for 250 min. The plate was read at 415/630 nm as described above. Based on our previous study (16) , the yield of heme converted BH was calculated by the following equation [1] . The results are shown in Fig. 2 . The yield of BH reached maximum, approximately 80%, at 0.012 g/l of Tween 20 ( Fig. 2A) and at 250 min (Fig. 2B) , indicating a relatively high efficiency to convert heme into BH in the presence of Tween 20. The crystal growth curves showed a sigmoidal pattern (Fig. 2B) , in a good agreement with previous reports, describing the transition from a metastable state to a stable equilibrium state, suggesting that Tween 20 plays a role in stabilizing nuclei of BH (27) . To our surprise, the rate of Tween 20-induced BH formation is faster than that of other assays using initiators such as lipids and pre-formed BH.
The characteristics of purified BH were further confirmed by infrared spectroscopy as described previously (15 Percentage of inhibition of BH by drugs was then described as the follow:
% inhibition = (1-f) * 100 = 100 * (A sample -A min ) / (A control -A min ) [3] The values obtained from duplicate assays were plotted, and the IC 50 values, concentration inhibiting 50% of heme crystallization, were calculated graphically. Our results showed that using Tween 20 has several advantages over using current initiators, for instances: (i) the assay is fast and based on a simple technique using a microplate reader, which is available in most labs; (ii) the Tween 20-based assay is not expensive for large-scale screening; (iii) the method is a convenient method that requires no fresh preparation of inducers; (iv) Tween 20 can be prepared in stock solution and require no strict conditions for storage; (v) the assay does not use pyridine, or mutagenic and carcinogenic agents; (vi) the assay uses a simple 96-well plate, which requires no purifying or transferring steps, promising an ideal highthroughput screening of antimalarial candidates.
In conclusion, our inhibition assay of BH formation using Tween 20 is cheap, reproducible, non-toxic, and is more convenient than other assays for large-scale screening of novel antimalarials. Figure 3 

